Fri, Oct 18, 2024
The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal affective disorder.
More >
Thu, Sep 12, 2024
There was a sharp decline in the shares of Granules India today. The objections issued in Form 483 are serious. Why Rolled Granules?
Tue, Aug 20, 2024
Granules India announced that its subsidiary, Granules Pharmaceuticals Inc, has received approval from the US FDA for a generic version of Glycopyrrolate Oral Solution, 1 mg/5 mL. This anticholinergic medication is indicated for pediatric patients aged 3 to 16 years with neurological conditions associated with drooling.
Thu, Jan 14, 2021
Makar Sankranti 2021 Stock Picks with Anil Singhvi - Auspicious and Significant Occasion: Zee Business Managing Editor Anil Singhvi talked to a panel of market experts and asked them to reveal their stocks that could generate good return for investors.
Fri, Nov 27, 2020
In today’s edition of 'News Par Views' show, Zee Business Managing Editor Anil Singhvi spoke to Sandip Neogi, Chief Financial Officer (CFO) of Granules India, a leader in API (Active Pharmaceutical Ingredient) manufacturing in the country. Neogi spoke about the recent buzz regarding the stake sale in company and much more. (#NewsParViews)
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
